Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 33, 2010, Pages 14757-14762

  Miller, F DeWolfe ^a   Abu Raddad, Laith J ^b,c,d  

^a UNIVERSITY OF HAWAII   (United States)

^b Cornell University ^*  (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d USA   (United States)

Author keywords

Iatrogentic transmission; Incidence; Mathematical modeling; Middle east and north africa; Parenteral transmission

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

AGE; AGE DISTRIBUTION; ARTICLE; DISEASE ASSOCIATION; EGYPT; ENDEMIC DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IATROGENIC DISEASE; INCIDENCE; MATHEMATICAL MODEL; PREVALENCE; PRIORITY JOURNAL; VIRUS TRANSMISSION; ADOLESCENT; ADULT; BLOOD; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL; VIROLOGY;

HEPATITIS C VIRUS;

ADOLESCENT; ADULT; EGYPT; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; YOUNG ADULT;

EID: 77957054972     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008877107     Document Type: Article

References (60)

1. Khawaja ZA, Gibney L, Ahmed AJ, Vermund SH (1997) HIV/AIDS and its risk factors in Pakistan. AIDS 11:843-848.
2. World Bank Group (2005) World Bank Update 2005: HIV/AIDS in Pakistan (World Bank, Washington, DC).
3. Yerly S, et al. (2001) Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 184:369-372.
4. Abu-Raddad L, et al. (2010) Characterizing the HIV/AIDS epidemic in the Middle East and North Africa. Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication.
5. Laraqui O, et al. (2008) Assessing knowledge, attitude, and practice on occupational blood exposure in caregiving facilities, in Morocco (in French). Med Mal Infect 38:658-666.
6. Zafar A, Aslam N, Nasir N, Meraj R, Mehraj V (2008) Knowledge, attitudes and practices of health care workers regarding needle stick injuries at a tertiary care hospital in Pakistan. J Pak Med Assoc 58:57-60.
7. Hossini CH, et al. (2000) [Knowledge and attitudes of health care professionals with respect to AIDS and the risk of occupational transmission of HIV in 2 Moroccan hospitals]. Sante 10:315-321.
8. Yemen Ministry of Health National Strategic Framework for the Control and Prevention of HIV/AIDS in the Republic of Yemen (Yemen Ministry of Health, Sana, Yemen).
9. Kennedy M, O'Reilly D, Mah MW (1998) The use of a quality-improvement approach to reduce needlestick injuries in a Saudi Arabian hospital. Clin Perform Qual Health Care 6:79-83.
10. Askarian M, Mirzaei K, McLaws ML (2006) Attitudes, beliefs, and infection control practices of Iranian dentists associated with HIV-positive patients. Am J Infect Control 34:530-533.
11. Askarian M, Mirzaei K, Cookson B (2007) Knowledge, attitudes, and practice of Iranian dentists with regard to HIV-related disease. Infect Control Hosp Epidemiol 28:83-87.
12. Kabbash IA, et al. (2007) Risk perception and precautions taken by health care workers for HIV infection in haemodialysis units in Egypt. East Mediterr Health J 13:392-407.
13. Janjua NZ, Hutin YJ, Akhtar S, Ahmad K (2006) Population beliefs about the efficacy of injections in Pakistan's Sindh province. Public Health 120:824-833.
14. Altaf A, et al. (2004) Determinants of therapeutic injection overuse among communities in Sindh, Pakistan. J Ayub Med Coll Abbottabad 16:35-38.
15. Hauri AM, Armstrong GL, Hutin YJ (2004) The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 15:7-16.
16. Mujeeb SA (1993) Blood transfusion - a potential source of HIV/AIDS spread. J Pak Med Assoc 43:1.
17. Hassan NF, et al. (1994) HIV infection in renal dialysis patients in Egypt. AIDS 8:853.
18. El Sayed NM, et al. (2000) Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt. J Infect Dis 181:91-97.
19. Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436-2441.
20. Kamel MA, et al. (1992) High HCV prevalence in Egyptian blood donors. Lancet 340:427.
21. MohamedMK, et al. (2005) Intrafamilial transmission of hepatitis C in Egypt. Hepatology 42:683-687.
22. Saleh DA, et al. (2008) Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg 102:921-928.
23. Frank C, et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
24. Talaat M, et al. (2003) Overview of injection practices in two governorates in Egypt. Trop Med Int Health 8:234-241.
25. Talaat M, et al. (2006) Evolution of infection control in Egypt: Achievements and challenges. Am J Infect Control 34:193-200.
26. El-Zanaty F, Way A (2009) Egypt Demographic and Health Survey 2008. Egyptian: Ministry of Health (El-Zanaty and Associates and Macro International, Cairo), pp 431.
27. Kleinbaum D, Kupper L, Morgenstern H (1982) Epidemiologic Research: Principles and Quantitative Methods (John Wiley & Sons, New York), pp 519.
28. Zou S, Fang CT, Dodd RY (2008) A method for estimating incidence rate of infectious diseases among first-time blood donors. Transfusion 48:1827-1832.
29. Leske MC, Ederer F, Podgor M (1981) Estimating incidence from age-specific prevalence in glaucoma. Am J Epidemiol 113:606-613.
30. Lehman EM, Wilson ML (2009) Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 16:650-658.
31. Saidel T, Sokal D, Rice J, Buzingo T, Hassig S (1996) Validation of a method to estimate age-specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data. Am J Epidemiol 144:214-223.
32. Abdel-Hamid M, et al. (2002) Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 40:1656-1659.
33. CAPMAS (2009) Center for Public Mobilization and Statistics. Available at: http://www.capmas.gov.eg/. Accessed September 2, 2009.
34. United Nations, Department of Economic and Social Affairs, Population Division (2008) World Population Prospects: The 2008 Revision (United Nations, New York).
35. Measure DHS (2010) Demographic and Health Surveys. Available at: http://www.measuredhs.com/start.cfm. Accessed October 14, 2009.
36. Morgenstern H (1982) Uses of ecologic analysis in epidemiologic research. Am J Public Health 72:1336-1344.
37. Ismail AM, Ziada HN, Sheashaa HA, Shehab El-Din AB (2009) Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: A glimmer of hope. Eur J Intern Med 20:490-493.
38. Mohamad M (2004) Epidemiology of HCV in Egypt. Afro-Arab Liver J 3:41-52.
39. Farghaly AG, Barakat RM (1993) Prevalence, impact and risk factors of hepatitis C infection. J Egypt Public Health Assoc 68:63-79.
40. Farghaly AG, Mansour GA, Mahdy NH, Yousri A (1998) Hepatitis B and C virus infections among patients with gingivitis and adult periodontitis: Seroprevalence and public health importance. J Egypt Public Health Assoc 73:707-735.
41. Lurie Y, et al. (2007) Acute hepatitis C in Israel: A predominantly iatrogenic disease? J Gastroenterol Hepatol 22:158-164.
42. Medhat A, et al. (2002) Hepatitis c in a community in Upper Egypt: Risk factors for infection. Am J Trop Med Hyg 66:633-638.
43. Hassan AA, Khalil R (2000) Hepatitis C in dialysis patients in egypt: Relationship to dialysis duration, blood transfusion, and liver disease. Saudi J Kidney Dis Transpl 11:72-73.
44. Kamel MA, et al. (1994) The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 88:501-509.
45. Darwish NM, Abbas MO, Hady SI, Mohammed TA (1995) Study of the high prevalence of HCV in Egypt. J Egypt Public Health Assoc 70:397-414.
46. Abdel-Aziz F, et al. (2000) Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatology 32:111-115.
47. Nafeh MA, et al. (2000) Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63:236-241.
48. el-Sadawy M, et al. (2004) Hepatitis C virus infection at Sharkia Governorate, Egypt: Seroprevalence and associated risk factors. J Egypt Soc Parasitol 34(1, Suppl) 367-384.
49. Arafa N, et al. (2005) Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 43:418-424.
50. Darwish NM, Abbas MO, Abdelfattah FM, Darwish MA (1992) Hepatitis C virus infection in blood donors in Egypt. J Egypt Public Health Assoc 67:223-236.
51. el Gohary A, et al. (1995) High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 59:155-161.
52. Darwish MA, et al. (1993) Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49:440-447.
53. Arthur RR, et al. (1997) Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 91:271-274.
54. Bassily S, Hyams KC, Fouad RA, Samaan MD, Hibbs RG (1995) A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse. Am J Trop Med Hyg 52:503-505.
55. Tanaka Y, et al. (2004) Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 58:191-195. (Pubitemid 38183970)
56. Rao MR, et al. (2002) Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2:29.
57. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R (1996) High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: A pilot study. Am J Trop Med Hyg 54:554-558.
58. el-Sayed HF, Abaza SM, Mehanna S, Winch PJ (1997) The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop 68:229-237.
59. Habib M, et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248-253.
60. Eassa S, Eissa M, Sharaf SM, Ibrahim MH, Hassanein OM (2007) Prevalence of hepatitis C virus infection and evaluation of a health education program in el-ghar village in zagazig, egypt. J Egypt Public Health Assoc 82:379-404.